Efficacy of Dabrafenib Plus Trametinib Combination in Patients with BRAF V600E-Mutant NSCLC in Real-World Setting: GFPC 01-2019 by Auliac, Jean-Bernard, Bayle, Sophie, Do, Pascal, Le Garff, Gwenaëlle, Roa, Magali, Falchero, Lionel, Huchot, Eric, Quéré, Gilles, Jeannin, Gaëlle, Métivier, Anne-Cécile, Hobeika, Joëlle, Guisier, Florian, Chouaid, Christos

Get full text

Carboplatin plus etoposide versus topotecan as second-line treatment for patients with sensitive relapsed small-cell lung cancer: an open-label, multicentre, randomised, phase 3 tr... by Baize, Nathalie, Monnet, Isabelle, Greillier, Laurent, Geier, Margaux, Lena, Hervé, Janicot, Henri, Vergnenegre, Alain, Crequit, Jacky, Lamy, Regine, Auliac, Jean-Bernard, Letreut, Jacques, Le Caer, Hervé, Gervais, Radj, Dansin, Eric, Madroszyk, Anne, Renault, Patrick-Aldo, Le Garff, Gwenaëlle, Falchero, Lionel, Berard, Henri, Schott, Roland, Saulnier, Patrick, Chouaid, Christos

Get full text

Circulating free tumor-derived DNA to detect EGFR mutations in patients with advanced NSCLC: French subset analysis of the ASSESS study by Denis, Marc G, Lafourcade, Marie-Pierre, Le Garff, Gwenaëlle, Dayen, Charles, Falchero, Lionel, Thomas, Pascal, Locher, Chrystèle, Oliviero, Gérard, Licour, Muriel, Reck, Martin, Normanno, Nicola, Molinier, Olivier

Get full text

Lung cancer trends and tumor characteristic changes over 20 years (2000–2020): Results of three French consecutive nationwide prospective cohorts’ studies by Debieuvre, Didier, Molinier, Olivier, Falchero, Lionel, Locher, Chrystèle, Templement-Grangerat, Dorine, Meyer, Nicolas, Morel, Hugues, Duval, Yannick, Asselain, Bernard, Letierce, Alexia, Trédaniel, Jean, Auliac, Jean-Bernard, Moreau, Lionel, Corre, Romain, Couraud, Sébastien, Freijat, Faraj Al, Sheikh, Waad Al, Amrane, Karim, Auliac, Jean-Bernard, Banciu, Nicolae, Bedossa, Alexandra, Belle, Antoine, Belmont, Laure, Benmammar, Kheir Eddine, Bernardi, Marie, Beynel, Pascal, Bizieux-Thaminy, Acya, Bonnefoy, Philippe, Briens, Éric, Brun, Philippe, Bugnet, Anne-Sophie, Chablais, Laetitia, Chiappa, Anne-Marie, Chikouche, Reda, Christiann, François, Clarot, Caroline, Corre, Romain, Courdeau-Labourie, Joelle, Crequit, Jacky, Dayen, Charles, Debieuvre, Didier, Decroisette, Chantal, Dehette, Stéphanie, Delafosse, Christian, Delmas, Christina, Dot, Jean-Marc, Dujon, Cécile, Dumont, Patrick, Dussopt, Christine, Duval, Fatima, Falchero, Lionel, Ghalloussi-Tebai, Yannick, Jaafar, Mohamad, Jeandeau, Serge, Julien, Sylvie, Kraemer, Jean Philippe, Kuntz, Pierre, Lamotte, Florence, Larive, Sébastien, Laurent, Thomas, Floch, Hervé Le, Garff, Gwenaëlle Le, Lecuyer, Emmanuelle, Doubliez, Marguerite Lepoulain, Levrat, Virginie, Maetz, Edith, Marichy, Catherine, Martignac, Bénédicte, Marty, Clothilde, Masson, Philippe, Maurer, Cyril, Meniai, Vincent, De Faverges, Geoffroy Milliet, Molinier, Olivier, Monnet, Isabelle, Moreau, Lionel, Morel, Hugues, Mosser, Laurent, Neidhardt, Anne-Catherine, Nunes, David, Obert, Julie, Pante, Vanessa, Paysse, Magalie, Peloni, Jean-Michel, Perrin, Christophe, Petit, Lidia, Popa, Mihai, Rabut, Hong, Redureau, Élise, Schneider, Sophie, Slaouti, Philippe, Tavernier, Jean-Yves, Templement-Grangerat, Dorine, Thirard, Laurence, Thomassin, Séverine, Tiercin, Marie, Tredaniel, Jean, Tudor, Andreea, Turlotte, Amélie, Virally, Jérôme

Get full text

Management and outcomes of non–small cell lung cancer patients with rapid progression under second‐or‐more‐line immune checkpoint inhibitors: ERORECI study (GFPC 2016‐04) by Vergnenegre, Alain, Geier, Margaux, Guisier, Florian, Lamy, Regine, Comet, Bénédicte, Le Garff, Gwenaelle, Do, Pascal, Janicot, Henri, Morel, Hugues, Decroisette, Chantal, Andre, Michel, Falchero, Lionel, Paleiron, Nicolas, Monnet, Isabelle

Get full text

Potential Antiangiogenic Treatment Eligibility of Patients with Squamous Non-Small-Cell Lung Cancer: EPISQUAMAB Study (GFPC 2015-01) by Vergnenègre, Alain, Basse, Victor, Le Garff, Gwenaelle, Bylicki, Olivier, Dubos-Arvis, Catherine, Comet, Bénédicte, Marcq, Marie, Le Treut, Jacques, Auliac, Jean-Bernard, Madroszyk, Anne, Fraboulet, Gislaine, Crequit, Jacky, Thomas, Pascal, Paleiron, Nicolas, Monnet, Isabelle

Get full text

Atezolizumab versus docetaxel for patients with previously treated non-small-cell lung cancer (POPLAR): a multicentre, open-label, phase 2 randomised controlled trial by Fehrenbacher, Louis, Dr, Spira, Alexander, MD, Ballinger, Marcus, PhD, Kowanetz, Marcin, PhD, Vansteenkiste, Johan, Prof, Mazieres, Julien, Prof, Park, Keunchil, Prof, Smith, David, MD, Artal-Cortes, Angel, MD, Lewanski, Conrad, MD, Braiteh, Fadi, MD, Waterkamp, Daniel, MD, He, Pei, PhD, Zou, Wei, PhD, Chen, Daniel S, MD, Yi, Jing, PhD, Sandler, Alan, MD, Rittmeyer, Achim, MD

Get full text

Safety and Efficacy of Immune Checkpoint Inhibitors in Patients With Cancer and Preexisting Autoimmune Disease: A Nationwide, Multicenter Cohort Study by Tison, Alice, Quéré, Gilles, Misery, Laurent, Funck‐Brentano, Elisa, Danlos, François‐Xavier, Routier, Emilie, Robert, Caroline, Loriot, Yohann, Lambotte, Olivier, Bonniaud, Bertille, Scalbert, Camille, Maanaoui, Sarah, Lesimple, Thierry, Martinez, Stéphanie, Marcq, Marie, Chouaid, Christos, Dubos, Catherine, Brunet‐Possenti, Florence, Stavris, Chloé, Chiche, Laurent, Beneton, Nathalie, Mansard, Sandrine, Guisier, Florian, Doubre, Hélène, Skowron, François, Aubin, François, Zehou, Ouidad, Roge, Christophe, Lambert, Mickaël, Pham‐Ledard, Anne, Beylot‐Barry, Marie, Veillon, Rémi, Kramkimel, Nora, Giacchero, Damien, De Quatrebarbes, Julie, Michel, Catherine, Auliac, Jean‐Bernard, Gonzales, Gilles, Decroisette, Chantal, Le Garff, Gwenaelle, Carpiuc, Ioana, Vallerand, Hervé, Nowak, Emmanuel, Cornec, Divi, Kostine, Marie

Get full text

Safety and efficacy of second-line metronomic oral vinorelbine-atezolizumab combination in stage IV non-small-cell lung cancer: An open-label phase II trial (VinMetAtezo) by Vergnenegre, Alain, Monnet, Isabelle, Ricordel, Charles, Bizieux, Acya, Curcio, Hubert, Bernardi, Marie, Corre, Romain, Guisier, Florian, Hominal, Stéphane, Le Garff, Gwenaelle, Bylicki, Olivier, Locher, Chrystèle, Geier, Margaux, Chouaïd, Christos, Robinet, Gilles

Get full text

Impact of KRAS G12C mutation in patients with advanced non-squamous non-small cell lung cancer treated with first-line pembrolizumab monotherapy by Justeau, Grégoire, Huchot, Eric, Simonneau, Yannick, Roa, Magali, Le Treut, Jacques, Le Garff, Gwenaelle, Bylicki, Olivier, Schott, Roland, Bravard, Anne-Sophie, Tiercin, Marie, Lamy, Régine, De Chabot, Gonzague, Marty, Adina, Moreau, Diane, Locher, Chrystèle, Bernier, Cyril, Chouaid, Christos, Descourt, Renaud

Get full text

Multicenter phase II trial of nintedanib plus docetaxel in second-line treatment in advanced non-squamous non-small cell lung cancer patients refractory to first-line platin-based... by Auliac, Jean-Bernard, Monnet, Isabelle, Bizieux, Acya, Greillier, Laurent, Geier, Margaux, Falchero, Lionel, Le Garff, Gwenaelle, Lamy, Régine, Guisier, Florian, Ricordel, Charles, Chouaid, Christos, Vergnenegre, Alain

Get full text

Safety and efficacy of immunotherapy using a double-dose regimen in advanced non-small cell lung cancer (NSCLC): results of IDEE study by Pierre, Clémence, Le Guen, Yannick, Giordanengo, Caroline, Goter, Thomas, Léna, Hervé, Niel, Clémence, De Chabot, Gonzague, Tiercin, Marie, Le Garff, Gwenaelle, Zimmermann, François, Le Cornu, Quentin, Ricordel, Charles

Get full text

Clinical Characteristics of Patients with Advanced ALK-Translocated Non-small Cell Lung Cancers and Long-Term Responses to Crizotinib (CRIZOLONG GFPC 05-19 Study) by Dhamelincourt, Estelle, Descourt, Renaud, Rousseau-Bussac, Gaelle, Doubre, Hélène, Decroisette, Chantal, Demontrond, Pierre, Le Garff, Gwenaelle, Falchero, Lionel, Huchot, Eric, Vieillot, Sabine, Corre, Romain, Kazulinski, Laure, Bizieux, Acya, Bigay-Gamé, Laurence, Morel, Hugues, Molinier, Olivier, Chouaïd, Christos, Guisier, Florian

Get full text